Share this postExperimental Gene TherapyFemales have More Adverse Events with BNT162b2!Copy linkFacebookEmailNotesMoreFemales have More Adverse Events with BNT162b2!Very Strong Signal regarding disproportionate Adverse Events and Adverse Events of Special Interest in Females. Revised with numbers verified using Joel Smalley's 2.1 data file. Changes in Notes.Robert W. Chandler, MD MBAAug 13, 20226Share this postExperimental Gene TherapyFemales have More Adverse Events with BNT162b2!Copy linkFacebookEmailNotesMore2ShareSex Diffs F Substack490KB ∙ PDF fileDownloadDownload Thanks for reading Experimental Gene Therapy! Subscribe for free to receive new posts and support my work.Subscribe
Thank you for reading them.
Burkhardt 2 is almost ready to go, 106 slides mostly histopath.
Part 3 will be a series of histopath cases from the published literature.
Part 4 will be an analysis and synthesis.
The goal is to determine if we are dealing with a cluster of new diseases.
Excellent! Thank you for your work!